Christoph Schell - 07 Dec 2021 Form 4 Insider Report for HP INC (HPQ)

Role
Chief Commercial Officer
Signature
/s/ Rick Hansen as Attorney-in-Fact for Christoph Schell
Issuer symbol
HPQ
Transactions as of
07 Dec 2021
Net transactions value
-$2,023,691
Form type
4
Filing time
09 Dec 2021, 16:58:27 UTC
Previous filing
18 Nov 2021
Next filing
22 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HPQ Common Stock Options Exercise $0 +109,454 +246% $0.000000 153,906 07 Dec 2021 Direct
transaction HPQ Common Stock Tax liability $2,023,691 -54,269 -35% $37.29 99,637 07 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HPQ Restricted Stock Units Award +72,942 72,942 07 Dec 2021 Common Stock 72,942 Direct F2, F3
transaction HPQ Performance Adjusted Restricted Stock Units Award +42,137 42,137 07 Dec 2021 Common Stock 42,137 Direct F4
transaction HPQ Performance Contingent Stock Options Award +193,719 193,719 07 Dec 2021 Common Stock 193,719 $37.29 Direct F5
transaction HPQ Restricted Stock Units Options Exercise -37,594 -34% 73,198 07 Dec 2021 Common Stock 37,594 Direct F2, F6
transaction HPQ Restricted Stock Units Options Exercise -39,905 -52% 37,399 07 Dec 2021 Common Stock 39,905 Direct F2, F7
transaction HPQ Restricted Stock Units Options Exercise -31,955 -100% 0 07 Dec 2021 Common Stock 31,955 Direct F2, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by HP to satisfy tax withholding upon vesting.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.
F3 On 12/7/2021, the reporting person was granted 72,942 restricted stock units RSUs, one-third of which vest annually over three years on each of 12/7/2022, 12/7/2023 and 12/7/2024. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.
F4 On 12/7/2021, the reporting person was granted 42,137 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/2024, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.
F5 The performance contingent stock options granted on 12/7/2021 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions.
F6 As previously reported, on 12/7/2020, the reporting person was granted 109,797 RSUs, 36,599 of which vested on 12/7/2021 and 36,599 of which is scheduled to vest on each of 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 995 vested dividend equivalent rights.
F7 As previously reported, on 12/6/2019, the reporting person was granted 112,195 RSUs, 37,398 of which vested on each of 12/7/2020 and 12/7/2021, and 37,399 of which is scheduled to vest on 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,507 vested dividend equivalent rights.
F8 As previously reported, on 12/7/2018, the reporting person was granted 87,222 RSUs, 29,074 of which vested on each of 12/7/2019, 12/7/2020 and 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,881 vested dividend equivalent rights.